Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol

Francesco Danilo Tiziano, Lorena Di Pietro, Eugenio Maria Mercuri, Marika Pane, Emanuela Abiusi, Simona Fiori, Giovanni Baranello, Maria Gabriella Vita, Maria Gabriella Vita, Maria Barbara Pasanisi, Corrado Angelini, Gianni Sorarù, Alessandra Gaiani, Tiziana Mongini, Liliana Vercelli, Giuseppe Vita, Gianluca Vita, Sonia Messina, Roberta Petillo, Luigia PassamanoLuisa Politano, Angela Campanella, Renato Mantegazza, Lucia Morandi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol'. Together they form a unique fingerprint.

Medicine & Life Sciences